Suven Life Sciences Ltd. - Research Center
530239 SUVEN Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 11.69 | 13.54 | 11.84 | 13.48 | 14.41 |
| Expenses | |||||
| Material consumed | 0.72 | - | - | - | - |
| Manufacturing expenses | 0.26 | - | - | - | - |
| Personnel expenses | 16.53 | 15.77 | 17.46 | 15.29 | 14.60 |
| Selling expenses | - | - | - | - | - |
| Adminstrative expenses | 25.12 | 25.51 | 31.02 | 28.74 | 35.08 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 42.63 | 41.28 | 48.49 | 44.03 | 49.68 |
| Operating profit | -30.94 | -27.74 | -36.64 | -30.55 | -35.26 |
| Other recurring income | 21.13 | 8.45 | 5.32 | 7.75 | 14.04 |
| Adjusted PBDIT | -9.81 | -19.29 | -31.33 | -22.79 | -21.23 |
| Financial expenses | 0.16 | 0.29 | 0.53 | 0.82 | 0.54 |
| Depreciation | 6.50 | 6.54 | 4.39 | 4.35 | 4.17 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | -16.47 | -26.13 | -36.25 | -27.95 | -25.94 |
| Tax charges | -1.00 | - | - | -5.32 | -12.18 |
| Adjusted PAT | -15.46 | - | - | -22.63 | -13.75 |
| Non recurring items | 7.40 | 6.19 | -0.15 | -0.31 | -0.30 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | -8.07 | -19.94 | -36.40 | -22.94 | -14.05 |
| Earnigs before appropriation | 133.43 | 141.49 | 161.43 | 197.83 | 220.77 |
| Equity dividend | - | - | - | - | - |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | - |
| Retained earnings | 133.43 | 141.49 | 161.43 | 197.83 | 220.77 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis